Cardiac Monitoring Market Analysis, Size, Trends | 2019-2025 | MedCore
- Year: 2019
- Scope: 2015-2025
- Region: Europe, United States
- Pages: 117
- Type: MedCore
Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs.
Globally, between the growing non-invasive and minimally-invasive cardiac output segments, and the rapidly declining PAC market, the total cardiac output market will be relatively stable over the forecast period. The non-invasive and minimally-invasive cardiac output markets will be driven by the increased awareness of the efficacy of CO monitoring. This measurement has become an integral part of critical care practice and may help in facilitating improved patient outcomes. Operating rooms (ORs) have traditionally been the primary users of cardiac output monitoring and pulmonary artery catheters (PACs). Newer therapies are geared toward quickly identifying patient conditions on the front line, namely within intensive care units (ICUs) and emergency rooms (ERs), where CO may be used as an early warning indicator for circulatory disturbances.
Report Regional Coverage
Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:
- United States
- Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
The Only Medical Device Market Research With:
|✔ Unit Sales Growth Analysis
✔ Average Selling Prices
✔ Competitor Shares by Segment & Country
✔ SKU-Level Research Methods
✔ The Lowest Acquisition Cost
Highly Detailed Segmentation
- Pulmonary Artery Catheter Market
- Minimally Invasive Cardiac Output Monitoring Market
- Non-Invasive Cardiac Output Monitoring Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Cardiac Monitoring Market Share Insights
Edwards Lifesciences leads the U.S. and Europe cardiac output monitoring market. This strong position is due to their control of the pulmonary artery catheter segment, with the Swan-Ganz™ PACs, a leading position in the minimally invasive market and well-established presence in the non-invasive segment. Edwards Lifesciences’ extensive catheter product line includes thermodilution, oximetry, pacing and continuous output catheters, as well as femoral vein insertion and pulmonary angiography catheters. Edwards Lifesciences was also present in the heart valve therapy, critical care, cardiac surgery, vascular therapies and transcatheter valve intervention product categories.
As the pulmonary catheter market continues to decline, Edwards Lifesciences has shifted their focus to markets with less-invasive technologies. Their Vigileo™ cardiac output monitoring device is a flexible solution for minimally invasive cardiac output monitoring and may be used with the FloTrac™ sensor or PreSep™ and PediaSat™ oximetry catheters for more comprehensive hemodynamic management.
With regards to the non-invasive market, Edwards Lifesciences’ ClearSight™ system leverages ccNexfin™ non-invasive monitoring technology and uses simple to apply, reusable finger cuffs for the monitoring of hemodynamic parameters. The minimally invasive FloTrac™ and non-invasive ClearSight™ systems have also been integrated into their EV1000™ clinical platform.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Patient Monitoring Equipment – MedSuite
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.